Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| Fosrenol | Other Identifier | Company Internal |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To measure lanthanum concentrations in bone in patients with hyperphosphatemia receiving dialysis
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Arm 1 | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Lanthanum Carbonate (BAY77-1931) | Drug | BAY77-1931 750mg, in the morning, day and evening |
|
| Measure | Description | Time Frame |
|---|---|---|
| Changes in pre-dialysis serum phosphate levels | Every 2 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Achievement rate of the target predialysis serum phosphate levels (3.5 mg/dL and 5.5 mg/dL) | Every 2 weeks | |
| Changes in corrected serum calcium level | Every 2 weeks | |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Bayer Study Director | Bayer | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Isesaki | Gunma | 379-2211 | Japan | |||
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 21426511 | Derived | Shigematsu T, Tokumoto A, Nakaoka A, Arisaka H. Effect of lanthanum carbonate treatment on bone in Japanese dialysis patients with hyperphosphatemia. Ther Apher Dial. 2011 Apr;15(2):176-84. doi: 10.1111/j.1744-9987.2010.00898.x. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D054559 | Hyperphosphatemia |
| ID | Term |
|---|---|
| D010760 | Phosphorus Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| C119467 | lanthanum carbonate |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Changes in the product of serum calcium and phosphate |
| Every 2 weeks |
| Changes in serum intact-PHT levels | Every 2 weeks |
| Changes in bone metabolism markers | Every 2 weeks |
| Yonago |
| Tottori |
| 683-0002 |
| Japan |